Sara Jawad

Sara is an Associate on the Life Science team at Industrifonden. Her passion lies in supporting science-driven innovations that have the potential to advance healthcare and create meaningful impact for patients. She is particularly drawn to early-stage drug development, where cutting-edge research is translated into therapies with real clinical impact.

Sara holds an M.Sc. in Chemical Engineering from KTH Royal Institute of Technology and has completed executive education in Finance at the Stockholm School of Economics. Before joining Industrifonden, she gained valuable industry experience at AstraZeneca, where she developed a strong foundation in pharmaceutical process development and production.